EURETINA Innovation Spotlight (EIS)

Rapid Fire Presentations

Euretina Innovation Spotlight invites emerging biotech companies to present their cutting-edge innovations in retina. Presentation slots are extremely limited, and submissions will be subject to review for inclusion in the programme.

Selected companies will have the opportunity to deliver a 2-minute Rapid-Fire presentation to showcase their business/clinical strategy on 3rd September 2025, in Paris.

This is a great opportunity for you to introduce your company’s strategy in developing cutting-edge treatment options for retinal diseases, moving the field forward.

This submission portal is exclusively for industry personnel and should be presented by a C-suite representative of your company.

Please carefully review the Submission Guidelines before starting your submission.

Submission Guidelines

• All submissions must be in English and include the following details:
  – Company Details: Name and Business Sector
  – Name of the company’s designated speaker
  – Presentation Title (300 characters max)
  – Company & Presentation Outline (300 words max)
• Presentations may include:
  – Clinical innovation and business strategy, both short term (next 12
  months) and long term (next 5 years) from the perspective of your
  company.
  – Differentiation of your company/products in the competitive landscape
  – Any additional topics relevant to the audience
• Formula should, in general, be avoided.
• The first mention of any abbreviation or acronym must include the full term, followed by the abbreviation in parentheses. The abbreviation alone should be used thereafter.
• Presentation slots are extremely limited. The EIS Programme Committee will review all submissions and accept only those that meet the required criteria.
• Accepted submissions will be granted a 2-minute Rapid-Fire presentation slot during an EIS session on 3rd September 2025.
• All companies will be informed about the acceptance status of their proposal by email in May 2025.